Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single…

Overview of attention for article published in PharmacoEconomics, September 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 95 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Healtheconbot, 08 Sep 2018

#HealthEconJA Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or…